Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Edge Biotech, formerly known as Edge Foods, is a biotechnology company specializing in the development of bioactive ingredients for the cosmetics, personal care, and life sciences industries. The company utilizes a proprietary stem cell technology platform to produce cell-conditioned media rich in growth factors, fatty acids, exosomes, and metabolites. These ingredients are designed to support cell growth and skin rejuvenation, offering a sustainable and ethical alternative to traditional animal-derived or synthetic components. Edge Biotech operates as a B2B supplier, aiming to establish its conditioned media as an industry standard for high-performance topical formulations and cellular agriculture applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EDGE Fashion.